Display options
Cite
Smith-Norowitz TA, Silverberg JI, Norowitz EM, et al. Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York. Hum Vaccin Immunother. 2021;17(11):4013-4014doi: 10.1080/21645515.2021.1948786.
Smith-Norowitz, T. A., Silverberg, J. I., Norowitz, E. M., Kohlhoff, S., & Hammerschlag, M. R. (2021). Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York. Human vaccines & immunotherapeutics, 17(11), 4013-4014. https://doi.org/10.1080/21645515.2021.1948786
Smith-Norowitz, Tamar A, et al. "Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York." Human vaccines & immunotherapeutics vol. 17,11 (2021): 4013-4014. doi: https://doi.org/10.1080/21645515.2021.1948786
Smith-Norowitz TA, Silverberg JI, Norowitz EM, Kohlhoff S, Hammerschlag MR. Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York. Hum Vaccin Immunother. 2021 Nov 02;17(11):4013-4014. doi: 10.1080/21645515.2021.1948786. Epub 2021 Jul 09. PMID: 34242124.
Copy Download .nbib Format: NLM
Share it on

Hum Vaccin Immunother. 2021 Nov 02;17(11):4013-4014. doi: 10.1080/21645515.2021.1948786. Epub 2021 Jul 09.

Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York.

Human vaccines & immunotherapeutics

Tamar A Smith-Norowitz, Jonathan I Silverberg, Esther M Norowitz, Stephan Kohlhoff, Margaret R Hammerschlag

Affiliations

  1. Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
  2. Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

PMID: 34242124 DOI: 10.1080/21645515.2021.1948786

Abstract

The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot

Keywords: COVID-19; COVID-19 vaccine; New York; seasonal influenza vaccine; vaccine hesitancy

Publication Types